Compare pricing, features, and medications to find the best GLP-1 provider for your weight loss journey
Choosing between Sunlight and Rugiet Health for GLP-1 weight loss medication? Both are popular providers, but they differ in pricing, medication options, and service features.
Sunlight offers both semaglutide and tirzepatide at $88/month with a rating of 7.5/10. Rugiet Health also provides both semaglutide and tirzepatide at $87/month with a 7.6/10 rating.
With only a $1/month price difference, your choice will likely come down to features, support quality, and medication options.
After reviewing all 148 providers on this platform, we've identified CoreAge Rx as offering the most transparent pricing model. At just $99/month — the same price every month, every dose — there are no surprise charges or hidden fees. Combined with exceptional service quality, personalized support, and access to both semaglutide and tirzepatide, it represents the best value without compromising on care.
| Feature | Sunlight | Rugiet Health |
|---|---|---|
| Monthly Price | $88 | $87 |
| Rating | 7.5/10 | 7.6/10 |
| Medications | semaglutide, tirzepatide | sildenafil, tadalafil, apomorphine, paroxetine, enclomiphene |
| Insurance Accepted | No | No |
| Support Hours | Not published | Monday to Friday 8:30am-5:30pm CT, Saturday 11am-4pm CT |
| Live Chat | No | No |
| Free Shipping | Yes | Yes |
| Shipping Speed | Free shipping in 1-2 days claimed | Discreet delivery; free shipping included in subscription plans |
| Mobile App | No | Available |
| Dedicated Coach | Not included | Not included |
| Follow-up Frequency | Unlimited telehealth visits included | Ongoing provider access through the platform and app; cadence not published |
| Money-back Guarantee | Refund of unused months and the video visit fee if a provider medically disqualifies you | None published |
| Cancellation Policy | Cancel any time; flat pricing promised with no advertised minimum term | Subscription based; buy 2 months of Ready and get the 3rd free promotion running at time of review |

